FDA Clearance Didn't Save Pear Therapeutics From Bankruptcy
Pear Therapeutics had FDA clearance, clinical trials and tens of millions spent on reimbursement — and still went bankrupt in 2023. Here's why institutional markets break the Silicon Valley playbook.
